While further studies are underway to assess their efficacy for opioid, cocaine, and stimulant use disorders, current findings suggest that GLP-1 RAs may offer new avenues for addressing maladaptive reward-driven behaviors beyond obesity
The final approved dosing, if and when retatrutide receives FDA approval, will be determined by the regulatory review process and may differ from the trial protocols
Two Different Mechanisms Retatrutide is a triple agonist: GLP-1 suppresses appetite and slows digestion, GIP improves insulin sensitivity, and glucagon increases energy expenditure and fat oxidation three distinct pathways working together
Lean Proteins (Your Muscles Best Friend) Chicken breast, turkey, tofu, eggs, Greek yogurt, cottage cheese, fish Aim for 80120g of protein daily (or more, based on your weight) Why